Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Fibroblast growth factor homologous factors tune arrhythmogenic late NaV1.5 current in calmodulin binding–deficient channels
Jeffrey Abrams, Daniel Roybal, Nourdine Chakouri, Alexander N. Katchman, Richard Weinberg, Lin Yang, Bi-xing Chen, Sergey I. Zakharov, Jessica A. Hennessey, Uma Mahesh R. Avula, Johanna Diaz, Chaojian Wang, Elaine Y. Wan, Geoffrey S. Pitt, Manu Ben-Johny, Steven O. Marx
Jeffrey Abrams, Daniel Roybal, Nourdine Chakouri, Alexander N. Katchman, Richard Weinberg, Lin Yang, Bi-xing Chen, Sergey I. Zakharov, Jessica A. Hennessey, Uma Mahesh R. Avula, Johanna Diaz, Chaojian Wang, Elaine Y. Wan, Geoffrey S. Pitt, Manu Ben-Johny, Steven O. Marx
View: Text | PDF
Research Article Cardiology

Fibroblast growth factor homologous factors tune arrhythmogenic late NaV1.5 current in calmodulin binding–deficient channels

  • Text
  • PDF
Abstract

The Ca2+-binding protein calmodulin has emerged as a pivotal player in tuning Na+ channel function, although its impact in vivo remains to be resolved. Here, we identify the role of calmodulin and the NaV1.5 interactome in regulating late Na+ current in cardiomyocytes. We created transgenic mice with cardiac-specific expression of human NaV1.5 channels with alanine substitutions for the IQ motif (IQ/AA). The mutations rendered the channels incapable of binding calmodulin to the C-terminus. The IQ/AA transgenic mice exhibited normal ventricular repolarization without arrhythmias and an absence of increased late Na+ current. In comparison, transgenic mice expressing a lidocaine-resistant (F1759A) human NaV1.5 demonstrated increased late Na+ current and prolonged repolarization in cardiomyocytes, with spontaneous arrhythmias. To determine regulatory factors that prevent late Na+ current for the IQ/AA mutant channel, we considered fibroblast growth factor homologous factors (FHFs), which are within the NaV1.5 proteomic subdomain shown by proximity labeling in transgenic mice expressing NaV1.5 conjugated to ascorbate peroxidase. We found that FGF13 diminished late current of the IQ/AA but not F1759A mutant cardiomyocytes, suggesting that endogenous FHFs may serve to prevent late Na+ current in mouse cardiomyocytes. Leveraging endogenous mechanisms may furnish an alternative avenue for developing novel pharmacology that selectively blunts late Na+ current.

Authors

Jeffrey Abrams, Daniel Roybal, Nourdine Chakouri, Alexander N. Katchman, Richard Weinberg, Lin Yang, Bi-xing Chen, Sergey I. Zakharov, Jessica A. Hennessey, Uma Mahesh R. Avula, Johanna Diaz, Chaojian Wang, Elaine Y. Wan, Geoffrey S. Pitt, Manu Ben-Johny, Steven O. Marx

×

Figure 2

Late Na+ current is not increased in cardiomyocytes expressing IQ/AA NaV1.5.

Options: View larger image (or click on image) Download as PowerPoint
Late Na+ current is not increased in cardiomyocytes expressing IQ/AA NaV...
(A–D) Exemplar whole cell Na+ current traces of ventricular cardiomyocytes isolated from nontransgenic, pWT, IQ/AA, and F1759A mice. Experiments designed to assess late Na+ current using a 190 ms depolarization from a holding potential of –110 to –30 mV in the absence and presence of 500 μM ranolazine or 40 μM TTX; intracellular solution contained 5 mM Na+ and extracellular solution contained 100 mM Na+. Horizontal scale bars: 50 ms; vertical scale bars: 10 pA/pF. (E) Graph of fraction of late Na+ current normalized to peak Na+ current. Mean ± SEM, ****P < 0.0001 by Kruskal-Wallis test with Dunn’s multiple comparison test. n = 23, 25, 29, and 31 cardiomyocytes from left to right. (F) Multichannel record from pseudo-WT myocyte shows rapid Na+ channel activation and inactivation, followed by a rare opening in the late phase, following 50 ms of depolarization (gray shaded region). Inset shows lone NaV1.5 opening to unitary current level (dashed line) in the late phase. Vertical scale bar: 10 pA; horizontal scale bar: 100 ms. (G) Normalized ensemble-average open probability relation computed from 50–80 stochastic records. Inset shows low levels of late PO following 50 ms of depolarization. Vertical scale bar: 25% for normalized PO (PO[t]/PO,peak). PO(t), time-dependent open probability; PO,peak denotes the peak open probability. (H and I) Multichannel recordings of Na+ channels from IQ/AA mice show minimal late current similar to pWT myocytes. Format as in F and G. (J and K) Appreciable late Na+–channel openings were detected for F1759A mutant. Format as in F and G. (L) Graph of PO normalized to peak PO. Mean ± SEM, **P < 0.001 by Kruskal-Wallis test, **P < 0.01 by Dunn’s multiple comparison test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts